JCI Insight · 2021 · 27 citations · 13 references
MedicineOncologyRadiation OncologyApoptosisDna RepairRadiobiologyBiological Effects Of RadiationCellular Radiation ResponseDna Damage SignalingRadiation TherapyRadiation-induced Cell DeathRadiobiological ConsiderationsApoptosis After IrradiationApoptosis Of Endothelial CellsDna Damage Response TargetingEndothelial ApoptosisPreclinical Drug DevelopmentRadiation CountermeasuresRadiation-induced ApoptosisRepair Of Ionizing Radiation-induced Breaks
After 9/11, threat of nuclear attack on American urban centers prompted government agencies to develop medical radiation countermeasures to mitigate hematopoietic acute radiation syndrome (H-ARS) and higher-dose gastrointestinal acute radiation syndrome (GI-ARS) lethality. While repurposing leukemia drugs that enhance bone marrow repopulation successfully treats H-ARS in preclinical models, no mitigator potentially deliverable under mass casualty conditions preserves GI tract. Here, we report generation of an anti-ceramide 6B5 single-chain variable fragment (scFv) and show that s.c. 6B5 scFv delivery at 24 hours after a 90% lethal GI-ARS dose of 15 Gy mitigated mouse lethality, despite administration after DNA repair was complete. We defined an alternate target to DNA repair, an evolving pattern of ceramide-mediated endothelial apoptosis after radiation, which when disrupted by 6B5 scFv, initiates a durable program of tissue repair, permitting crypt, organ, and mouse survival. We posit that successful preclinical development will render anti-ceramide 6B5 scFv a candidate for inclusion in the Strategic National Stockpile for distribution after a radiation catastrophe.
13
Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice
François Paris, Zvi Fuks, Anthony D. Kang et al. · Science · 2001 · 1.3K citations
Crypt Base Columnar Stem Cells in Small Intestines of Mice Are Radioresistant
Guoqiang Hua, Tin Htwe Thin, Regina Feldman et al. · Gastroenterology · 2012 · 201 citations · Full text
Medicine, Cell Biology, Oncology +16